Valeant Weighs New Viramidine Dosing After Phase III Stumble
Prediction of a 2007 launch is unaltered by failure of first pivotal hepatitis C trial to meet one of two co-primary endpoints.
Prediction of a 2007 launch is unaltered by failure of first pivotal hepatitis C trial to meet one of two co-primary endpoints.